Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)

Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, Kohei Shitara, Reo Sato, Tetsuo Akimoto, Takahiro Kinoshita

Akio Kaito, Masanori Tokunaga, Reo Sato, Takahiro Kinoshita, Gastric Surgery Division, National Cancer Center Hospital East, Kashiwa 277-8577, Japan

Akio Kaito, Takeshi Kuwata, Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa 277-8577, Japan

Akio Kaito, Kohei Shitara, Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan

Akio Kaito, Tetsuo Akimoto, Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan

Takeshi Kuwata, Kohei Shitara, Exploratory Oncology Research and Clinical Trial Center(EPOC), National Cancer Center Hospital East, Kashiwa 277-8577, Japan

Tetsuo Akimoto, Department of Radiation Oncology, National Cancer Center Hospital East,Kashiwa 277-8577, Japan

Abstract Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacked. Akio Kaito, the first author, belonged to Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan.

Key Words: Correction

CORRECTION

Correction to: Kaito A, Kuwata T, Tokunaga M, Shitara K, Sato R, Akimoto T,Kinoshita T. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer.World J Clin Cases2019; 7(15): 1964-1977 [PMID: 31423428 DOI:10.12998/wjcc.v7.i15.1964].

In this article[1], one of the affiliation of the first author was lacked. Akio Kaito, the first author, belonged to Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan. We apologize for the error.